SCHEMBL3824402

SCHEMBL3824402

N#Cc1ccc(N(Cc2ccc(C(F)(F)F)cc2)C2CCNCC2)nn1

nearest known ligand 0.46

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 12/20 0.46
SLC6A4 P31645 12/20 0.46
SLC6A3 Q01959 6/20 0.41
TACR1 P25103 3/20 0.38
HTR2C P28335 2/20 0.37
KDM1A O60341 1/20 0.36
MAOB P27338 1/20 0.36
DCUN1D1 Q96GG9 1/20 0.35
NOS2 P35228 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3814247 0.88 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3TACR1HTR2C
SCHEMBL3823147 0.86 TACR1 (0.44) SLC6A2SLC6A4SLC6A3TACR1
SCHEMBL3818883 0.86 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3NOS2
SCHEMBL3821207 0.84 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3TACR1
SCHEMBL3820758 0.83 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3NOS2
SCHEMBL3818638 0.83 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3TACR1NOS2
SCHEMBL3821333 0.82 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3NOS2
SCHEMBL3820183 0.80 CTSL (0.36) SLC6A2SLC6A4SLC6A3KDM1AMAOB
SCHEMBL3818198 0.79 NOS2 (0.47) SLC6A2SLC6A4SLC6A3TACR1NOS2
SCHEMBL4306762 0.72 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3TACR1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091938-A1 PIPERIDINYLAMINO-PYRIDAZINES AND THEIR USE AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2009-08-26 EP disclosed
WO-2008068277-A1 PIPERIDINYLAMINO-PYRIDAZINES AND THEIR USE AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-06-12 WO disclosed